What are the normal shock index values for children by age, and how should an elevated shock index be evaluated and managed?

Shock Index in Children

The shock index, pediatric age-adjusted (SIPA) is the appropriate metric for evaluating hemodynamic status in children, with age-specific cutoffs that more accurately identify severe injury and need for intervention than the adult shock index of >0.9.

Normal SIPA Values by Age

The established age-adjusted cutoffs for elevated SIPA are 1, 2:

• Ages 1-3 years: >1.22
• Ages 4-6 years: >1.22
• Ages 7-12 years: >1.0
• Ages 13-16 years: >0.9
• Infants <1 year: Emerging data suggests age-specific vital sign-based cutoffs, though consensus is still developing 3

These thresholds are calculated as heart rate divided by systolic blood pressure, adjusted for the maximum normal heart rate and minimum normal systolic blood pressure for each age group.

Clinical Significance and Performance

Elevated SIPA identifies children at significantly higher risk for:

• Blood transfusion within 24 hours (27% vs 20% with unadjusted SI) 1
• Emergency operation (30% vs 13% with hypotension alone) 4
• Endotracheal intubation (40% vs 17% with hypotension alone) 4
• ICU admission and longer hospital length of stay 2, 5
• In-hospital mortality (11% vs 7% with unadjusted SI) 1

Critical point: SIPA detects compensated shock before hypotension develops. Hypotension in children represents late, decompensated shock with 54.4% mortality versus 1.5% in normotensive patients 6. Waiting for hypotension to trigger intervention results in preventable deaths.

Evaluation Algorithm for Elevated SIPA

When SIPA is elevated, immediately assess:

1. Clinical perfusion markers 7:

   • Capillary refill (goal ≤2 seconds)
   • Peripheral pulse quality (central vs peripheral differential)
   • Skin temperature and color (warm vs cold shock)
   • Mental status
   • Urine output (goal >1 mL/kg/h)

2. Hemodynamic parameters 8:

   • Obtain intra-arterial blood pressure monitoring for fluid-refractory shock or vasopressor requirement
   • Do not rely on blood pressure alone as therapeutic target
   • Integrate multiple clinical and hemodynamic parameters

3. Laboratory markers 7:

   • ScvO2 (goal >70%)
   • Lactate and anion gap
   • Hemoglobin (goal ≥10 g/dL in shock)
   • INR, glucose, calcium

Management Protocol for Elevated SIPA

Immediate Resuscitation (First Hour) 7:

Fluid resuscitation:

• Administer 20 mL/kg boluses of isotonic crystalloid or 5% albumin via push or pressure bag
• Repeat boluses up to 200 mL/kg in first hour if no signs of fluid overload (most children require 40-60 mL/kg)
• Monitor for rales, increased work of breathing, gallop rhythm, hepatomegaly
• Correct hypoglycemia and hypocalcemia immediately

Hemodynamic support:

• If fluid-refractory after 40-60 mL/kg, initiate vasoactive support
• Cold shock (vasoconstricted, weak pulses, cool extremities): Central epinephrine 0.05-0.3 μg/kg/min
• Warm shock (vasodilated, bounding pulses): Norepinephrine
• Central dopamine is alternative first-line agent via central access

Therapeutic Goals 7:

• Capillary refill ≤2 seconds
• Normal mental status
• Cardiac index 3.3-6.0 L/min/m² (not just >2.0 as in adults)
• ScvO2 >70%
• MAP appropriate for age (≥65 mmHg for children >12 years) 8
• Urine output >1 mL/kg/h
• Normal lactate and anion gap

Monitoring Requirements 7:

For persistent shock despite initial therapy:

• Continuous intra-arterial blood pressure
• Central venous pressure and ScvO2
• Cardiac output measurement (echocardiography, thermodilution, or pulse contour analysis)
• Serial lactate, INR, glucose

Key Clinical Pearls

SIPA improves discrimination over standard shock index: Only 28% of children have elevated SIPA versus 50% with unadjusted SI >0.9, reducing false positives while capturing truly severe injuries 1.

SIPA is unaffected by fever: Unlike other vital sign-based tools, SIPA maintains predictive accuracy regardless of fever, race, or sex 5.

Early transfusion matters: Patients with elevated SIPA who received earlier blood transfusion (4.5 vs 17.8 hours) had reduced mortality 6. Elevated SIPA should trigger consideration of massive transfusion protocol activation.

Improvement in SIPA reflects therapeutic success 7: As stroke volume increases with appropriate fluid and inotropic therapy, heart rate reflexively decreases and blood pressure improves, normalizing the SIPA. This indicates restored cardiac output and perfusion.

Common Pitfalls

• Do not wait for hypotension: By the time children become hypotensive, mortality exceeds 50% 6
• Do not use SIPA in isolation: Integrate with clinical examination, perfusion markers, and laboratory values 8
• Recognize shock phenotype: Cold shock requires vasodilators with volume loading; warm shock requires vasopressors 7
• Avoid undertreating young children: Infants have limited heart rate reserve and cannot compensate for reduced stroke volume by increasing heart rate as adults can 7